Citadel Advisors’s Surrozen SRZN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.03M Buy
35,469
+20,729
+141% +$497K ﹤0.01% 7589
2025
Q4
$333K Buy
14,740
+865
+6% +$14K ﹤0.01% 9911
2025
Q3
$179K Buy
13,875
+3,424
+33% +$35.9K ﹤0.01% 11379
2025
Q2
$93.4K Buy
+10,451
New +$95.5K ﹤0.01% 11397
2024
Q4
Sell
-10,930
Closed -$129K 15351
2024
Q3
$129K Buy
+10,930
New +$96.5K ﹤0.01% 10776
2022
Q1
Sell
-763
Closed -$74K 14528
2021
Q4
$74K Buy
+763
New +$86.5K ﹤0.01% 12995

Other funds holding SRZN

Citadel Advisors's SRZN Position: Q1 2026 in Review

Citadel Advisors increased its Surrozen (SRZN) stake by 141% in Q1 2026, buying an estimated $497K and bringing the position to 35,469 shares worth $1.03M. The position accounts for ﹤0.01% of the portfolio, ranked #7589.

Citadel Advisors first reported a position in SRZN in Q4 2021 and has held it in 6 quarters since. 59 funds tracked by Wall St. Rank hold SRZN as of Q1 2026.

  • Citadel Advisors held 35,469 shares of Surrozen worth $1.03M as of Q1 2026.
  • Citadel Advisors bought 20,729 Surrozen shares in Q1 2026, an estimated $497K.
  • Surrozen made up ﹤0.01% of Citadel Advisors's portfolio in Q1 2026, its #7589 holding.
  • Citadel Advisors first reported a position in Surrozen in Q4 2021 and has held it in 6 quarters since.
  • 59 funds tracked by Wall St. Rank held Surrozen as of Q1 2026.

Based on Citadel Advisors's 13F filing for Q1 2026, filed 15 May 2026.